Login to Your Account

ImmunoGen Leverages High Stock Price with $84M Offering

By Trista Morrison

Monday, May 23, 2011
Despite having a healthy amount of cash in its coffers, ImmunoGen Inc. capitalized on the fact that its stock is heading toward a 10-year high and raised $84 million in a public offering.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription